$STLD

Anderson James Stanley sold $2.7M of STLD

Anderson James Stanley (Senior Vice President) sold 10,000 shares of STEEL DYNAMICS INC (STLD) at an average of $268.70 ($267.35–$269.93, $2.69M total) across 4 trades on 2026-06-05.

Original reporting
SEC EDGAR · Anderson James Stanley
Published Jun 8, 2026, 6:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 6:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$STLD
Neutral
medium confidence
Mentioned
$STLD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STLDNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale amount and that it was not executed under a 10b5-1 plan, which can affect how traders interpret insider intent.

02

Market read

Primarily a sentiment/positioning input for STLD; no guidance, contract, or operational change is disclosed.

03

What to watch

The filing doesn’t state motives, whether other insiders are selling/buying, or whether the company has concurrent fundamental catalysts; traders should cross-check other insider activity and upcoming company events.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-08; sale executed 2026-06-05.

Background

The article is an SEC Form 4 insider transaction disclosure for Steel Dynamics (STLD).

Company-level read

Ticker impact

$STLDNeutralMedium confidence
Context

SEC Form 4 shows STLD SVP Anderson James Stanley sold 10,000 shares in open-market trades for ~$2.69M, not under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and may fade unless follow-on selling or fundamentals change.

Evidence & confidence

The article discloses a single insider’s sale size (~$2.69M) and confirms it was not under a pre-arranged 10b5-1 plan, which can increase interpretive sensitivity, but it provides no new business or guidance information.

Market effects

Limited read-through to steel/industrial peers; this is company-specific insider activity with no sector datapoint.

None indicated.

None indicated.

Counterpoint

Insider sales often reflect diversification, taxes, or scheduled liquidity needs; absence of 10b5-1 does not necessarily imply negative expectations.

Key entities

  • Steel Dynamics

    STLD, the company whose insider transaction was reported on SEC EDGAR.

  • Anderson James Stanley

    Senior Vice President who sold 10,000 STLD shares across four trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GNRCHighAI 9/10

Generac’s $8 Billion Deal, CoreWeave’s $3.7 Billion Notes and $7.7 Billion Baldwin Buyout Move US Stocks Over the Week

Generac (GNRC) surged 25% after an $8B deal with Amazon to supply backup generators for data centers. CoreWeave raised $3.7B in convertible notes for AI infrastructure. Baldwin Insurance agreed to a $7.7B take-private deal. Marvell (MRVL) and GlobalFoundries expanded a chip production deal. Nebius raised GPU cloud service prices. Steel Dynamics (STLD) and Nucor (NUE) issued weak Q3 guidance despite strong shipments.

$STLDMed

STLD Gets Street Backing Despite Lower-Than-Estimated Q3 Guidance – Wells Fargo Remains Constructive On Margin Upside

Steel Dynamics (STLD) shares fell 5% after Q3 earnings guidance of $5.34-$5.38 per share, below the $5.60 consensus. Analysts adjusted targets: JPMorgan lowered to $272 (Neutral), Wells Fargo raised to $257 (Overweight). STLD expects higher steel margins and strong demand across multiple sectors, with Q3 aluminum earnings improving. Year-to-date, shares are up 33%.

$XENEHighAI 8/10

Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Ses

Xenon Pharmaceuticals (XENE) shares dropped 27.6% to $41.51 in pre-market trading after pausing enrollment in psychiatry studies due to adverse events. Other stocks moving lower include Frontline (FRO), Biohaven (BHVN), Stewards (SWRD), Steel Dynamics (STLD), and Array Technologies (ARRY). Steel Dynamics expects Q3 EPS of $5.34-$5.38, up from previous periods.

$XENEHigh

Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade

U.S. stock futures rose Friday. Xenon Pharmaceuticals (XEN) fell 24% after pausing trials. Netflix (NFLX) dropped 2.1% following a downgrade and price target cut by Wells Fargo. Array Technologies (ARRY) declined 3.1% after a downgrade and lower price target from UBS. Steel Dynamics (STLD) fell 3.4% on below-expectation earnings guidance. Frontline (FRO) dropped 6% ex-dividend. StubHub (ETSY) rose 3.5% on an upgrade from Citi. Dynatrace (DT) gained 1.2% after an upgrade from Needham. Etsy (ETSY)